Early Alzheimer's Disease
TRAILRUNNER-ALZ 3 is a clinical study by Eli Lilly investigating whether an investigational medicine can slow the progression of Alzheimer’s disease. The study focuses on individuals with early symptoms or at risk.
Be part of a study that could shape the future of Memory Care!
Get started now
Who is it for?
Between 55 to 80 years old
Have no to mild issues with your memory
Willing to obtain a blood test as part of the study
Have a reliable study partner (spouse, partner, family member, friend, or someone else whose job is to help you)
Benefits of participanting
Access to potential new treatments before they are widely available
Free medical care and health monitoring during the study
Contribute to advancing medical research and helping future generations
If you qualify, you may be compensated for your time and travel
A guide to clinical trials
Sign up
Find a clinical trial that’s right for you or a loved one.
Pre Screen
We’ll check your health history to match you with the right trial.
Screening
Come to our clinic for tests and evaluations to confirm eligibility.
Join the Study
Once eligible, you’ll begin the trial and receive care based on the study plan.
